When Signaling Pathways Collide: Positive and Negative Regulation of Toll-like Receptor Signal Transduction

Immunity

Volumn 29, Issue 1, 2008, Pages 12-20

  O'Neill, Luke A J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; DECTIN 1; GLUCOCORTICOID; LECTIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2;

HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 46749136412     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2008.06.004     Document Type: Review

References (84)

1. Abraham S.M., Lawrence T., Kleiman A., Warden P., Medghalchi M., Tuckermann J., Saklatvala J., and Clark A.R. Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J. Exp. Med. 203 (2006) 1883-1889
2. An H., Zhao W., Hou J., Zhang Y., Xie Y., Zheng Y., Xu H., Qian C., Zhou J., Yu Y., et al. SHP-2 phosphatase negatively regulates the Trif adaptor protein-dependent Type I interferon and proinflammatory cytokine production. Immunity 25 (2006) 919-928
3. An H., Hou J., Zhou J., Zhao W., Xu H., Zheng Y., Yu Y., Liu S., and Cao X. Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat. Immunol. 9 (2008) 542-550
4. Bouchon A., Facchetti F., Weigand M.A., and Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410 (2001) 1103-1107
5. Bowie A., Kiss-Toth E., Symons J.A., Smith G.L., Dower S.K., and O'Neill L.A. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 97 (2000) 10162-10167
6. Bowie A.G., and O'Neill L.A.J. The family of five: The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7 (2007) 353-364
7. Brikos C., Wait R., Begum S., O'Neill L.A., and Saklatvala J. Mass spectrometric analysis of the endogenous IL-1RI signalling complex formed after IL-1 binding, identifies IL-1RAcP, MyD88 and IRAK-4 as the stable components. Mol. Cell Proteomics 6 (2007) 1551-1559
8. Brown G.D., Taylor P.R., Reid D.M., Willment J.A., Williams D.L., Martinez-Pomares L., Wong S.Y., and Gordon S. Dectin-1 is a major beta-glucan receptor on macrophages. J. Exp. Med. 196 (2002) 407-412
9. Butler M.P., Hanly J.A., and Moynagh P.N. Kinase active IRAKs promote polyubiquination and degradation of the pellino family: direct evidence for pellino proteins being E3 ubiquitin ligases. J. Biol. Chem. 282 (2007) 29729-29737
10. Carty M., Goodbody R., Schröder M., Stack J., Moynagh P.N., and Bowie A.G. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat. Immunol. 7 (2006) 1074-1081
11. Castiblanco J., Varela D.C., Castaño-Rodríguez N., Rojas-Villarraga A., Hincapié M.E., and Anaya J.M. TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus. Infect. Genet. Evol. (2008) 10.1016/j.meegid.2008.03.001 in press. Published online March 12, 2008
12. Cirl C., Wieser A., Yadav M., Duerr S., Schubert S., Fischer H., Stappert D., Wantia N., Rodriguez N., Wagner H., et al. Nat. Med. 14 (2008) 399-406
13. Clark A.R. Anti-inflammatory functions of glucocorticoid genes. Mol. Cell. Endocrinol. 275 (2007) 79-97
14. Conze D.B., Wu C.J., Thomas J.A., Landstrom A., and Ashwell J.D. Lys (K)63-linked polyubiquitination of IRAK-1 is required for IL-1 receptor- and Toll-like receptor-mediated NF-kappaB activation. Mol. Cell. Biol. (2008) 10.1128/MCB.02098-07 in press. Published online March 17, 2008
15. Creagh E.M., and O'Neill L.A.J. TLRs, NLRs and RLRs: A trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 27 (2006) 352-357
16. Deng L., Wang C., Spencer E., Yang L., Braun A., You J., Slaughter C., Pickart C., and Chen Z.J. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103 (2000) 351-361
17. Dennehy K.M., Ferwerda G., Faro-Trinidade I., Pyz E., Willment J.A., Taylor P.R., Kerrigan A., Tsoni V., Gordon S., Meyer-Wentrup F., et al. Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors. Eur. J. Immunol. 38 (2008) 500-506
18. Dostert C., Pétrilli V., Van Bruggen R., Steele C., Mossman B.T., and Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320 (2008) 674-677
19. Doyle S.L., Jefferies C.A., and O'Neill L.A. Bruton's tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NF-kappa B activation by LPS. J. Biol. Chem. 280 (2005) 23496-23501
20. Doyle S.L., Jefferies C.A., Feighery C., and O'Neill L.A. Signaling by Toll-like receptors 8 and 9 requires Bruton's tyrosine kinase. J. Biol. Chem. 282 (2007) 36953-36960
21. Dunn-Siegrist I., Leger O., Daubeuf B., Poitevin Y., Depis F., Herren S., Kosco-Vilbois M., Dean Y., Pugin J., and Elson G. Pivotal involvement of Fc-gamma receptor IIA in the neutralisation of lipopolysaccharide signalling via a potent novel anti-TLR4 monoclonal antibody 15C1. J. Biol. Chem. 282 (2007) 34817-34827
22. Gray P., Dunne A., Brikos C., Jefferies C.A., Doyle S.L., and O'Neill L.A. MyD88 Adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction. J. Biol. Chem. 281 (2006) 10489-10495
23. Hamerman J.A., Tchao N.K., Lowell C.A., and Lanier L.L. Enhanced Toll-like receptor responses in the absence of signalling adaptor DAP12. Nat. Immunol. 6 (2005) 579-586
24. Hara H., Ishihara C., Takeuchi A., Imanishi T., Xue L., Morris S.W., Inui M., Takai T., Shibuya A., Saijo S., et al. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat. Immunol. 8 (2007) 619-629
25. Harte M.T., Haga I.R., Maloney G., Gray P., Reading P.C., Bartlett N.W., Smith G.L., Bowie A., and O'Neill L.A. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 197 (2003) 343-351
26. Hawn T.R., Dunstan S.J., Thwaites G.E., Simmons C.P., Thuong N.T., Lan N.T., Quy H.T., Chau T.T., Hieu N.T., Rodrigues S., et al. Polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. J. Infect. Dis. 194 (2006) 1127-1134
27. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., and Yoshida N. Taniguchi T.IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 (2005) 772-777
28. Horwood N.J., Mahon T., McDaid J.P., Campbell J., Mano H., Brennan F.M., Webster D., and Foxwell B.M. Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor alpha production. J. Exp. Med. 197 (2003) 1603-1611
29. Horwood N.J., Page T.H., McDaid J.P., Palmer C.D., Campbell J., Mahon T., Brennan F.M., Webster D., and Foxwell B.M. Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF production, but not IL6 production. J. Immunol. 176 (2006) 3635-3641
30. Jefferies C.A., Doyle S., Brunner C., Dunne A., Brint E., Wietek C., Walch E., Wirth T., and O'Neill L.A. Bruton's tyrosine kinase is a TIR domain binding protein that participates in NFkappa B activation by Toll-like receptor 4. J. Biol. Chem. 278 (2003) 26258-26264
31. Kagan J.C., and Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125 (2006) 943-955
32. Kagan J.C., Su T., Horng T., Chow A., Akira S., and Medzhitov R. Tram couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat. Immunol. 9 (2008) 361-368
33. Kanneganti T.D., Lamkanfi M., Kim Y.G., Chen G., Park J.H., Franchi L., Vandenabeele P., and Núñez G. Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 26 (2007) 433-443
34. Kanneganti T.D., Lamkanfi M., and Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity 27 (2007) 549-559
35. Kanneganti T.D., Ozören N., Body-Malapel M., Am A., Park J.H., Franchi L., Whitfield J., Barchet W., Colonna M., Vandenabeele P., et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440 (2006) 233-236
36. Kawagoe T., Sato S., Matsushita K., Kato H., Matsui K., Kumagai Y., Saitoh T., Kawai T., Takeuchi O., and Akira S. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat. Immunol. 9 (2008) 684-691
37. Keating S.E., Maloney G.M., Morna E.M., and Bowie A.G. IRAK-2 participates in multiple Toll-like receptor signaling pathways to NF-kappaB via activation of Traf6 ubiquitination. J. Biol. Chem. 282 (2007) 33435-33443
38. Khor C.C., Chapman S.J., Vannberg F.O., Dunne A., Murphy C., Ling E.Y., Frodsham A.J., Walley A., Kyrieleis O., Khan A., et al. A functional variant in MAL/TIRAP and protection against invasive pneumococcal disease, bacteraemia, malaria and tuberculosis. Nat. Genet. 39 (2007) 523-528
39. Kim Y., Zhou P., Qian L., Chuang J.Z., Lee J., Li C., Iadecola C., Nathan C., and Ding A. MyD88-5 links mitochondria, microtubules, and JNK3 in neurons and regulates neuronal survival. J. Exp. Med. 204 (2007) 2063-2074
40. Kim Y.G., Park J.H., Shaw M.H., Franchi L., Inohara N., and Nunez G. The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. Immunity 28 (2008) 246-257
41. Kobayashi K., Inohara N., Hernandez L.D., Galán J.E., Núñez G., Janeway C.A., Medzhitov R., and Flavell R.A. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416 (2002) 194-199
42. Lasa M., Abraham S.M., Boucheron C., Saklatvala J., and Clark A.R. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol. Cell. Biol. 22 (2002) 7802-7811
43. Latz E., Verma A., Visintin A., Gong M., Sirois C.M., Klein D.C., Monks B.G., McKnight C.J., Lamphier M.S., Duprex W.P., et al. Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat. Immunol. 8 (2007) 772-779
44. Lee K.G., Xu S., Wong E.T., Tergaonkar V., and Lam K.P. Bruton's tyrosine kinase separately regulates NF-kappaB p65relA activation and cytokine interleukin (IL)-10/IL-12 production in TLR9-stimulated B cells. J. Biol. Chem. 283 (2008) 11189-11198
45. Liljeroos M., Vuolteenaho R., Morath S., Hartung T., Hallman M., and Ojaniemi M. Bruton's tyrosine kinase together with PI 3-kinase are part of Toll-like receptor 2 multiprotein complex and mediate LTA induced Toll-like receptor 2 responses in macrophages. Cell. Signal. 19 (2007) 625-633
46. Mansell A., Simth R., Doyle S., Gray P., Fennen J.E., Crack P., Nicholson S., Hilton D.J., O'Neill L.A., and Hertzog P. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by targeting Mal for degradation. Nat. Immunol. 7 (2006) 148-155
47. Mariathasan S., Weiss D.S., Newton K., McBride J., O'Rourke K., Roose-Girma M., Lee W.P., Weinrauch Y., Monack D.M., and Dixit V.M. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440 (2006) 228-232
48. Martinon F. Detection of immune danger signals by NALP3. J. Leukoc. Biol. 83 (2008) 507-511
49. Martinon F., Pétrilli V., Mayor A., Tardivel A., and Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440 (2006) 237-241
50. Martinon F., Agostini L., Meylan E., and Tschopp J. Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr. Biol. 14 (2004) 1929-1934
51. McCoy C.E., Carpenter S., Palsson-McDermott E.M., Gearing L.J., and O'Neill L.A. Glucocorticoids inhibit IRF3 phosphorylation in response to Toll-like receptor-3 and -4 by targeting TBK1 activation. J. Biol. Chem. 283 (2008) 14277-14285
52. McGettrick A., Brint E.K., Palsson-McDermott E.M., Rowe D.C., Golenbock D.T., Gay N.J., Fitzgerald K.A., and O'Neill L.A. Trif-related adapter molecule is phosphorylated by PKC{epsilon} during Toll-like receptor 4 signaling. Proc. Natl. Acad. Sci. USA 103 (2006) 9196-9201
53. Meng F., and Lowell C.A. Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn. J. Exp. Med. 185 (1997) 1661-1670
54. Miggin S.M., Pålsson-McDermott E., Dunne A., Jefferies C., Pinteaux E., Banahan K., Murphy C., Moynagh P., Yamamoto M., Akira S., et al. NF-kappaB activation by the Toll-IL-1 receptor domain protein MyD88 adapter-like is regulated by caspase-1. Proc. Natl. Acad. Sci. USA 104 (2007) 3372-3377
55. Netea, M.G., Nold, C., Nold, M., Opitz, B., van den Meer, J., Kullberg, B.J., Van den Meer, J., and Dinarello, C.A. (2008) Monocytes are not macrophages: One-hit fresus tow-hit stimulation of LPS-driven activation of the human inflammasome for IL-1beta. Abstract 265, Keystone Symposium: Innate Immunity: Signalling Mechanisms.
56. Newman R.M., Salunkhe P., Godzik A., and Reed J.C. Identification and characterization of a novel bacterial virulence factor that shares homology with mammalian Toll/interleukin-1 receptor family proteins. Infect. Immun. 74 (2006) 594-601
57. Núñez Miguel R., Wong J., Westoll J.F., Brooks H.J., O'Neill L.A., Gay N.J., Bryant C.E., and Monie T.P. A dimer of the Toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins. PLoS ONE. 2 (2007) e788
58. Ogawa S., Lozach J., Benner C., Pascual G., Tangirala R.K., Westin S., Hoffmann A., Subramaniam S., David M., Rosenfeld M.G., and Glass C.K. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122 (2005) 707-721
59. Ordureau A., Smith H., Windheim M., Peggie M., Carrick E., Morrice N., and Cohen P. The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1. Biochem. J. 409 (2008) 43-52
60. Palmer C.D., Mutch B.E., Page T.H., Horwood N.J., and Foxwell B.M.J. Bmx regulates LPS-induced IL-6 and VEGF production via mRNA stability in rheumatoid synovial fibroblasts. Biochem. Biophys. Res. Commun. 370 (2008) 599-602
61. Palmer C.D., Mutch B.E., Workman S., McDaid J.P., Horwood N.J., and Foxwell B.M.J. Bmx tyrosine kinase regulates TLR4-induced IL-6 production in human macrophages independently of p38 MAPK and NF-kappaB activity. Blood 111 (2008) 1781-1788
62. Piao W., Song C., Chen H., Wahl L.M., Fitzgerald K.A., O'Neill L.A., and Medvedev A.E. Tyrosine phosphorylation of MyD88 adapter-like (Mal) is critical for signal transduction and blocked in endotoxin tolerance. J. Biol. Chem. 282 (2008) 3109-3119
63. Reily M.M., Pantoja C., Hu X., Chinenov Y., and Rogatsky I. The GRIP:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. EMBO J. 25 (2006) 108-117
64. Rothlin C.V., Ghosh S., Zuniga E.I., Oldstone M.B.A., and Lemke G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131 (2007) 1124-1136
65. Rowe D.C., McGettrick A.F., Latz E., Monks B.G., Gay N.J., Yamamoto M., Akira S., O'Neill L.A., Fitzgerald K.A., and Golenbock D.T. The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. Proc. Natl. Acad. Sci. USA 103 (2006) 6299-6304
66. Schmidt N.W., Thieu V.T., Mann B.A., Ahyi A.N., and Kaplan M.H. Bruton's tyrosine kinase is required for TLR-induced IL-10 production. J. Immunol. 177 (2006) 7203-7210
67. Shi M., Deng W., Bi E., Mao K., Ji Y., Lin G., Wu X., Tao Z., Li Z., Cai X., et al. TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation. Nat. Immunol. 9 (2008) 369-377
68. Stack J., Haga I.R., Schröder M., Bartlett N.W., Maloney G., Reading P.C., Fitzgerald K.A., Smith G.L., and Bowie A.G. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J. Exp. Med. 201 (2005) 1007-1018
69. Stitt T.N., Conn G., Gore M., Lai C., Bruno J., Radziejewski C., Mattsson K., Fisher J., Gies D.R., Jones P.F., et al. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell 80 (1995) 661-670
70. Tada H., Aiba S., Shibata K., Ohteki T., and Takada H. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect. Immun. 73 (2005) 7967-7976
71. Taneichi H., Kanegane H., Sira M.M., Futatani T., Agematsu K., Sako M., Kaneko H., Kondo N., Kaisho T., and Miyawaki T. Toll-like receptor signaling is impaired in dendritic cells from patients with X-linked agammaglobunemia. Clin. Immunol. 126 (2008) 148-154
72. Tanimura N., Saitoh S., Matsumoto F., Akahi-Takamura S., and Miyake K. Roles for LPS-dependent interaction and relocation of TLR4 and Tram in Trif-signaling. Biochem. Biophys. Res. Commun. 368 (2008) 94-99
73. Taylor P.R., Tsoni S.V., Willment J.A., Dennehy K.M., Rosas M., Findon H., Haynes K., Steele C., Botto M., Gordon S., and Brown G.D. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat. Immunol. 8 (2007) 31-38
74. Turer E.E., Tavares R.M., Mortier E., Hitotsumatsu O., Advincula R., Lee B., Shifrin N., Malynn B.A., and Ma A. Homeostatic MyD88-dependent signals cause lethal inflammation in the absence of A20. J. Exp. Med. 205 (2008) 451-464
75. Uematsu S., Sato S., Yamamoto M., Hirotani T., Kato H., Takeshita F., Matsuda M., Coban C., Ishii K.J., Kawai T., et al. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. J. Exp. Med. 201 (2005) 915-923
76. van Heel D.A., Ghosh S., Butler M., Hunt K., Foxwell B.M., Mengin-Lecreulx D., and Playford R.J. Synergistic enhancement of Toll-like receptor responses by NOD1 activation. Eur. J. Immunol. 35 (2005) 2471-2476
77. Wang C., Deng L., Hong M., Akkaraju G.R., Inoue J., and Chen Z.J. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412 (2001) 346-351
78. Watanabe T., Asano N., Murray P.J., Ozato K., Tailor P., Fuss I.J., Kitani A., and Strober W. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J. Clin. Invest. 118 (2008) 545-559
79. Weber A.N., Moncrieffe M.C., Gangloff M., Imler J.L., and Gay N.J. Ligand-receptor and receptor-receptor interactions act in concert to activate signaling in the Drosophila toll pathway. J. Biol. Chem. 280 (2005) 22793-22799
80. Wietek C., Miggin S.M., Jefferies C.A., and O'Neill L.A. Interferon regulatory factor-3-mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-kappa. J. Biol. Chem. 278 (2003) 50923-50931
81. Willment J.A., and Brown G.D. C-type lectin receptors in antifungal immunity. Trends Microbiol. 16 (2008) 27-32
82. Yamamoto M., Yaginuma K., Tsutsui H., Sagara J., Guan X., Seki E., Yasuda K., Yamamoto M., Akira S., Nakanishi K., et al. ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules. Genes Cells 9 (2004) 1055-1067
83. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., and Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5 (2004) 730-737
84. Zhao Q., Wang X., Nelin L.D., Yao Y., Matta R., Manson M.E., Baliga R.S., Meng X., Smith C.V., Bauer J.A., et al. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J. Exp. Med. 203 (2006) 131-140